US Patent 7482344 Tricyclic steroid hormone nuclear receptor modulators

Patent 7482344 was granted and assigned to Eli Lilly and Company on January, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 17 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 17 Sep, 2023

Edits made to:

Infobox (+5 properties)

Infobox

Patent Inventor Names

Donald Paul Matthews0

James Joseph Droste0

Jonathan Edward Green0

Michael Joseph Coghlan0

Prabhakar Kondaji Jadhav0

Edits on 15 Sep, 2023

"Add patent abstract"

Golden AI

edited on 15 Sep, 2023

Edits made to:

Article (+507 characters)

Article

Patent abstract

The present invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart disease, hypertension, rheumatoid arthritis or inflammation, comprising administering to a patient in thereof an effective amount of a compound of Formula (I).

Edits on 22 Jul, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 22 Jul, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=07482344

Edits on 25 May, 2023

"Remove leading 0 from patent number"

Golden AI